China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3

Rhea-AI Filing Summary

China SXT Pharmaceuticals, Inc. director Chee Yong Lip filed an initial Form 3 as a reporting person. This filing serves as a baseline disclosure of his status as an insider of the company. The submission does not report any stock transactions or holdings in this excerpt.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chee Yong Lip

(Last) (First) (Middle)

NO 83 LORONG 11A3 TAMAN

MALIHAH JALAN MATANG 93050

(Street)

KUCHING

(City) (State) (Zip)

MALAYSIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
01/20/2025

3. Issuer Name and Ticker or Trading Symbol
China SXT Pharmaceuticals, Inc. [ SXTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yong Lip Chee	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Chee Yong Lip’s Form 3 filing mean for China SXT Pharmaceuticals (SXTC)?

The Form 3 shows that Chee Yong Lip is now an insider of China SXT Pharmaceuticals as a director. It is an initial ownership report and, in this excerpt, does not list any specific share holdings or transactions.

Does the China SXT Pharmaceuticals (SXTC) Form 3 show any share purchases or sales?

No, this Form 3 excerpt shows no reported stock purchases, sales, option exercises, gifts, or other transactions. All transaction counters, including buy, sell, and derivative exercises, are listed as zero in the summary data.

What role does Chee Yong Lip have at China SXT Pharmaceuticals (SXTC)?

According to the Form 3 data, Chee Yong Lip is classified as a director of China SXT Pharmaceuticals. He is not shown as an officer or a ten percent owner in this excerpt, which focuses on his reporting status.

Why are there no holdings shown in this China SXT Pharmaceuticals (SXTC) Form 3 excerpt?

The structured data indicates zero holding entries and no derivative positions in the visible portion. That means this excerpt does not include any detailed share ownership table or option holdings for Chee Yong Lip.

Does the Form 3 for China SXT Pharmaceuticals (SXTC) mention any derivative securities?

No, the derivative summary section is empty and derivativeTransactionCount is zero. This indicates that, in the provided excerpt, there are no reportable options, warrants, or other derivative securities for Chee Yong Lip.